Welcome to SPP2395

SPP2395 is a collaboratively supported priority programme on microglia research. With more than 30 principal investigators in two funding periods, we are driving 36 innovative projects across more than 20 research institutes in Germany, Israel, the United Kingdom, Switzerland and Finland. Together, we advance rigorous, transparent science to deepen our understanding of microglia in health and disease.

Our Mission

Microglia are the resident macrophages of the CNS, coordinating homeostatic regulation and mounting first-line immune responses. After two decades revealing their heterogeneity, the field is moving beyond simple “homeostatic” versus “disease-associated” labels toward context-aware biology in intact tissue. SPP2395 prioritizes in vivo investigation and the translation of preclinical insights using human post-mortem tissue, humanized mouse models, iPSC-derived human microglia, and patient data.

News


Upcoming Events

Recent Publications

  • AuthorAuthor
    Cerebral ischaemic stroke results in altered mucosal antibody responses and host-commensal microbiota interactions
    Hurry, M., Posner, D.A., Wong, R., Grayston, A., Díaz-Marugan, L., Zhang, X., De Leon, B., Benakis, C., Waisman, A., McCulloch, L., Allan, S.M., Lawrence, C.B., Brough, D., Hepworth, M.R.
    Brain Behav Immun 131 (2025) doi: 10.1016/j.bbi.2025.106184 pmid: 41265660

Participating Institutions